TMSH (TransGlobal Assets) OCF Margin %: -99.19% (As of Dec. 2011)


What is TransGlobal Assets OCF Margin %?

TransGlobal Assets TMSH OCF Margin % is -99.19% as of Dec. 2011.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. TransGlobal Assets's Cash Flow from Operations for the six months ended in Dec. 2011 was $-0.12 Mil. TransGlobal Assets's Revenue for the six months ended in Dec. 2011 was $0.12 Mil. Therefore, TransGlobal Assets's OCF Margin % for the quarter that ended in Dec. 2011 was -99.19%.

As of today, TransGlobal Assets's current OCF Yield % is -35.47%.

The historical rank and industry rank for TransGlobal Assets's OCF Margin % or its related term are showing as below:

TMSH' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -99.19

TMSH's OCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 9.95 vs TMSH: -99.19

TransGlobal Assets OCF Margin % Related Terms

TransGlobal Assets OCF Margin % Historical Data

* Premium members only.

The historical data trend for TransGlobal Assets's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TransGlobal Assets OCF Margin % Chart

TransGlobal Assets Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
OCF Margin %
0.00 0.00 0.00 -100.00 -99.19

TransGlobal Assets Semi-Annual Data
Dec07 Dec08 Dec09 Dec10 Dec11
OCF Margin % 0.00 0.00 0.00 -100.00 -99.19

TMSH vs CLDOF: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TransGlobal Assets's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TransGlobal Assets OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TransGlobal Assets's OCF Margin % distribution charts can be found below:

* The bar in red indicates where TransGlobal Assets's OCF Margin % falls into.


TransGlobal Assets OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

TransGlobal Assets's OCF Margin for the fiscal year that ended in Dec. 2011 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2011 )/Revenue (A: Dec. 2011 )
=-0.122/0.123
=-99.19 %

TransGlobal Assets's OCF Margin for the quarter that ended in Dec. 2011 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2011 )/Revenue (Q: Dec. 2011 )
=-0.122/0.123
=-99.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -99.19% mean?
TransGlobal Assets (TMSH) has a OCF Margin % of -99.19% as of Dec. 2011. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TransGlobal Assets and its competitors.
Is TransGlobal Assets' OCF Margin % too high?
TransGlobal Assets' current OCF Margin % is -99.19%.
How does TransGlobal Assets' OCF Margin % compare to CLDOF?
TransGlobal Assets' OCF Margin % of -99.19% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TransGlobal Assets and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransGlobal Assets's current OCF Margin % is -99.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransGlobal Assets stock overvalued right now?
TransGlobal Assets (TMSH) has a current OCF Margin % of -99.19%. The current OCF Margin % is -99.19%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TransGlobal Assets (TMSH), the current OCF Margin % is -99.19% as of Dec. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TransGlobal Assets Business Description

Address No. 14, 5555 Sagamore Avenue, Portsmouth, NH, USA, 03801
TransGlobal Assets Inc through its subsidiary Mindwell Solutions Group LLC (MWSG), the company develops proprietary solutions that harness AI, biometric analysis, and behavioral data to address high-growth markets, including mental health, relationship wellness, performance analytics, and sports/entertainment. and also offers a pioneer in transforming the health and wellness industries through cutting-edge products and services. The products and services are focused on being at the forefront of the health and wellness sectors, developing technologies and solutions that are driving industry growth and transforming lives. The portfolio includes a range- of-products and services, from telemedicine platforms to wellness retreats and natural health remedies.